Literature DB >> 2991258

Identification of linoleic and oleic acids as endogenous Na+,K+-ATPase inhibitors from acute volume-expanded hog plasma.

M Tamura, H Kuwano, T Kinoshita, T Inagami.   

Abstract

Na+,K+-ATPase inhibitors have been found to exist in acutely saline-infused hog plasma, which also inhibit the specific binding of ouabain to Na+,K+-ATPase and the binding of digoxin to specific anti-digoxin antibody. Two of these inhibitors were purified by a combination of Amberlite XAD-2 adsorption chromatography and 3 steps of high-performance liquid chromatography. Reverse phase, high-performance liquid chromatography, mass spectrometry, and nuclear magnetic resonance spectrometry identified these substances as linoleic (18:2) and oleic acids (18:1). A significant increase in the ouabain-displacing activity was observed in hog plasma during saline infusion. The maximal level reached was approximately 10 times higher than that of the preinfusion plasma sample. The two unsaturated fatty acids contributed to approximately 52% of the total ouabain-displacing activity after 120 min of saline infusion. The increased fatty acid levels in volume-expanded plasma are sufficient for an extensive inhibition of Na+,K+-ATPase activity. These results strongly suggest that free unsaturated fatty acids in plasma regulate extracellular fluid volume in a pathological volume-expanded condition through modulation of Na+,K+-ATPase activity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2991258

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  Endogenous factors with immunological and biological activity similar to cardiac glycosides: biochemical and pathophysiological implications.

Authors:  A Clerico; G Mariani
Journal:  J Endocrinol Invest       Date:  1992-05       Impact factor: 4.256

Review 2.  In search of synaptosomal Na+,K(+)-ATPase regulators.

Authors:  G Rodríguez de Lores Arnaiz
Journal:  Mol Neurobiol       Date:  1992       Impact factor: 5.590

3.  Identification and characterization of a ouabain-like compound from human plasma.

Authors:  J M Hamlyn; M P Blaustein; S Bova; D W DuCharme; D W Harris; F Mandel; W R Mathews; J H Ludens
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

Review 4.  [Endogenous natriuretic and ouabain-like factors. Their potential role in volume and blood pressure regulation].

Authors:  H J Kramer; A Bäcker; G Krampitz; H Meyer-Lehnert; H Michel
Journal:  Klin Wochenschr       Date:  1990-11-16

Review 5.  Circulating digitalis-like factors.

Authors:  V M Buckalew
Journal:  Pediatr Nephrol       Date:  1988-04       Impact factor: 3.714

6.  Inhibition of human colonic (Na+ + K+)-ATPase by arachidonic and linoleic acid.

Authors:  H Allgayer; L Brown; W Kruis; E Erdmann; G Paumgartner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-04       Impact factor: 3.000

7.  Effects of direct renal arterial infusion of bufalin and ouabain in conscious sheep.

Authors:  N A Yates; J G McDougall
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

8.  Na/K-ATPase assay in the intact mice lung subjected to perfusion.

Authors:  Cassiano Felippe Gonçalves-de-Albuquerque; Patrícia Burth; Adriana Ribeiro Silva; Isabel Matos Medeiros de Moraes; Flora Magno Jesus de Oliveira; Ricardo Erthal Santelli; Aline Soares Freire; Mauricio Younes-Ibrahim; Hugo Caire de Castro-Faria-Neto; Mauro Velho de Castro-Faria
Journal:  BMC Res Notes       Date:  2014-11-15

9.  Oleic acid inhibits lung Na/K-ATPase in mice and induces injury with lipid body formation in leukocytes and eicosanoid production.

Authors:  Cassiano Felippe Gonçalves-de-Albuquerque; Patrícia Burth; Adriana Ribeiro Silva; Isabel Matos Medeiros de Moraes; Flora Magno de Jesus Oliveira; Ricardo Erthal Santelli; Aline Soares Freire; Patrícia Torres Bozza; Mauricio Younes-Ibrahim; Hugo Caire de Castro-Faria-Neto; Mauro Velho de Castro-Faria
Journal:  J Inflamm (Lond)       Date:  2013-10-31       Impact factor: 4.981

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.